Author:
Fabrizi Fabrizio,Messa Piergiorgio,Basile Carlo,Martin Paul
Publisher
Springer Science and Business Media LLC
Reference118 articles.
1. Kidney Disease: Improving Global Outcomes. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic kidney disease. Kidney Int. 73 (Suppl. 109), S1–S99 (2008).
2. Fabrizi, F. et al. Influence of hepatitis C virus (HCV) viraemia upon serum aminotransferase activity in chronic dialysis patients. Nephrol. Dial. Transplant. 12, 1394–1398 (1997).
3. Josselson, J., Kyser, B. A., Weir, M. R. & Sadler, J. H. Hepatitis B surface antigenemia in a chronic hemodialysis program: lack of influence on morbidity and mortality. Am. J. Kidney Dis. 6, 456–461 (1987).
4. Jha, R. et al. Hepatitis B associated liver disease in dialysis patients: role of vaccination. J. Nephrol. 6, 98–103 (1993).
5. Fabrizi, F. et al. Influence of hepatitis B virus viremia upon serum aminotransferase activity in dialysis population. Int. J. Artif. Organs 26, 1048–1055 (2003).
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献